Foley Hoag, along with five attorneys, have been recognized in the 2025 LMG Life Sciences U.S. Firm & Lawyer Rankings.
The firm was ranked in the following categories:
- Licensing & Collaboration
- Patent Prosecution
- Venture Capital
Additionally, the following attorneys were recognized:
- Barbara Fiacco (General Patent Litigation)
- Amy Mandragouras (Patent Strategy & Management)
- Anthony Mirenda (Non-IP Litigation & Enforcement)
- Jeff Quillen (Venture Capital)
- Donald Ware (General Patent Litigation)
LMG Life Sciences U.S. Firm & Lawyer Rankings identifies the leading law firms and attorneys in each practice area of the life sciences industry based on case evidence and interviews with clients and peers from other law firms.
Foley Hoag’s nationally recognized life sciences industry group represents more than 2,000 public and private clients, from biotechnology and pharmaceuticals to medical device and healthcare services. It draws on the talents of a wide variety of professionals, including former scientists, MDs and high-ranking government officials, whose collective insights and experience enable clients to address issues associated with the development, approval, commercialization, reimbursement and coverage of innovative medical products and services.
Learn more about the LMG Life Sciences U.S. Firm & Lawyer Rankings here.